Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVO · against 1,216 other Healthcare companies
Ranked #737 of 1,217 · scores higher than 39% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 30–39, including EVO · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -1.1% | 6.1% | 28% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 1.6% | 5.8% | 34% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 737 | 3.5B JPY (≈$24M) | 39 | 48 | |
| 737 | 3.1B EUR (≈$3.4B) | 39 | 47 | |
| 737 | 10.8B USD | 39 | 54 | |
| 737 | 558.5B INR (≈$6.7B) | 39 | 47 | |
| 737 | 551M USD | 39 | 27 | |
| 737 | 36.4B USD | 39 | 50 | |
| 737 | 964M EUR (≈$1.1B) | 39 | 58 | |
| 737 | 3.2B CHF (≈$3.6B) | 39 | 54 | |
| 737 | 16.2B THB (≈$453M) | 39 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score